Artykuły w czasopismach na temat „Factor VIII (FVIII)”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Factor VIII (FVIII)”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Yada, Koji, Kenichi Ogiwara, Masaru Shibata, Midori Shima i Keiji Nogami. "Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII". Thrombosis and Haemostasis 105, nr 06 (2011): 989–98. http://dx.doi.org/10.1160/th10-12-0781.
Pełny tekst źródłaYada, Koji, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama i Midori Shim. "Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII." Blood 114, nr 22 (20.11.2009): 3169. http://dx.doi.org/10.1182/blood.v114.22.3169.3169.
Pełny tekst źródłaNakajima, Yuto, Koji Yada, Keiji Nogami i Midori Shima. "A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation". Blood 132, Supplement 1 (29.11.2018): 1162. http://dx.doi.org/10.1182/blood-2018-99-115645.
Pełny tekst źródłaOgiwara, Kenichi, Keiji Nogami, Masahiro Okuda, Katsumi Nishiya, Masahiro Takeyama i Midori Shima. "Interactions of Factor VIII with Tissue Factor Contributes to the Acceleration of Factor Xa Generation in the Initiation Phase of Blood Coagulation." Blood 114, nr 22 (20.11.2009): 3177. http://dx.doi.org/10.1182/blood.v114.22.3177.3177.
Pełny tekst źródłaOgiwara, Kenichi, Keiji Nogami, Tetsuhiro Soeda, Tomoko Matsumoto, Katsumi Nishiya i Midori Shima. "Mechanisms of Factor VIII Activation by Recombinant Factor VIIa Analog through Tissue Factor-Independent Manner". Blood 112, nr 11 (16.11.2008): 1028. http://dx.doi.org/10.1182/blood.v112.11.1028.1028.
Pełny tekst źródłaMeeks, Shannon, Ernest T. Parker, Amy L. Dunn, John F. Healey i Pete Lollar. "Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model." Blood 114, nr 22 (20.11.2009): 27. http://dx.doi.org/10.1182/blood.v114.22.27.27.
Pełny tekst źródłaSoeda, Tetsuhiro, Keiji Nogami, Tomoko Matsumoto, Kenichi Ogiwara, Katsumi Nishiya i Midori Shima. "Tissue Factor-Dependent Activation of Factor VIII by Factor VIIa in the Early Phase of Blood Coagulation". Blood 112, nr 11 (16.11.2008): 1036. http://dx.doi.org/10.1182/blood.v112.11.1036.1036.
Pełny tekst źródłaMesser, Amanda S., Barbara Ulmasov, Yogesh Kumar, Kanagasabai Vadivel, Degang Zhong, Philip Fay i S. Paul Bajaj. "Epitope Mapping of a Monoclonal Antibody to Factor VIII That Inhibits Factor IXa:Factor VIIIa Interaction and Thrombin Activation of Factor VIII". Blood 118, nr 21 (18.11.2011): 1177. http://dx.doi.org/10.1182/blood.v118.21.1177.1177.
Pełny tekst źródłaZakas, Philip, Kristopher Knight, Ernest T. Parker, H. Trent Spencer, Eric Gaucher i Christopher B. Doering. "Bioengineering Coagulation Factor VIII through Ancestral Protein Reconstruction". Blood 126, nr 23 (3.12.2015): 123. http://dx.doi.org/10.1182/blood.v126.23.123.123.
Pełny tekst źródłaRadtke, Klaus-Peter, Dean Chamberlain, John H. Griffin i Andrew J. Gale. "Whole Blood Thromboelastogram Assays Demonstrate Prolonged Factor VIIIa Potency for Recombinant Disulfide Bond-Stabilized Factor VIII Variants." Blood 104, nr 11 (16.11.2004): 2976. http://dx.doi.org/10.1182/blood.v104.11.2976.2976.
Pełny tekst źródłaOgiwara, Kenichi, Midori Shima i Keiji Nogami. "Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms". Thrombosis and Haemostasis 106, nr 10 (2011): 665–74. http://dx.doi.org/10.1160/th11-04-0264.
Pełny tekst źródłaTakeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori i Midori Shima. "Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity". Thrombosis and Haemostasis 103, nr 01 (2010): 94–102. http://dx.doi.org/10.1160/th09-05-0338.
Pełny tekst źródłaShoko, Furukawa, Keiji Nogami, Kenichi Ogiwara i Midori Shima. "Mechanism of Tissue Factor (TF) Enhancing Factor (F)VIII Activity on FXa Generation in Initial Phase of Coagulation and Interaction Between TF and FVIII C2 Domain". Blood 128, nr 22 (2.12.2016): 1391. http://dx.doi.org/10.1182/blood.v128.22.1391.1391.
Pełny tekst źródłaWilhelm, Amelia R., Nicole A. Parsons, Benjamin J. Samelson-Jones, Robert J. Davidson, Charles T. Esmon, Rodney M. Camire i Lindsey A. George. "Activated protein C has a regulatory role in factor VIII function". Blood 137, nr 18 (6.05.2021): 2532–43. http://dx.doi.org/10.1182/blood.2020007562.
Pełny tekst źródłaRozenshteyn, Diana, i Andrew J. Gale. "Cathepsin G, a leukocyte protease, activates coagulation factor VIII". Thrombosis and Haemostasis 99, nr 01 (2008): 44–51. http://dx.doi.org/10.1160/th07-08-0495.
Pełny tekst źródłaHausl, Christina, Rafi U. Ahmad, Maria Sasgary, Christopher B. Doering, Pete Lollar, Günter Richter, Hans Peter Schwarz, Peter L. Turecek i Birgit M. Reipert. "High-dose factor VIII inhibits factor VIII–specific memory B cells in hemophilia A with factor VIII inhibitors". Blood 106, nr 10 (15.11.2005): 3415–22. http://dx.doi.org/10.1182/blood-2005-03-1182.
Pełny tekst źródłaDoshi, Bhavya, Courtney Cox, Bagirath Gangadharan, Christopher B. Doering i Shannon L. Meeks. "Factor VIII Supplementation Improves Recombinant VIIa Initiated Thrombin Generation in Hemophilia A Inhibitor Patient Plasmas". Blood 118, nr 21 (18.11.2011): 28. http://dx.doi.org/10.1182/blood.v118.21.28.28.
Pełny tekst źródłaZhong, Degang, Evgueni L. Saenko, Midori Shima, Matthew Felch i Dorothea Scandella. "Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX". Blood 92, nr 1 (1.07.1998): 136–42. http://dx.doi.org/10.1182/blood.v92.1.136.413k35_136_142.
Pełny tekst źródłaPonder, Katherine P. "FIXing Factor VIII inhibitors". Blood 119, nr 2 (12.01.2012): 325–26. http://dx.doi.org/10.1182/blood-2011-11-389486.
Pełny tekst źródłaPeerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson i in. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A". Blood 93, nr 7 (1.04.1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.
Pełny tekst źródłaPeerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson i in. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A". Blood 93, nr 7 (1.04.1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.407k21_2267_2273.
Pełny tekst źródłaTakeyama, Masahiro, Keiji Nogami, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori, Kohei Tatsumi, Yuri Fujita, Ichiro Tanaka, Akira Yoshioka i Midori Shima. "Characterization of an Anti-Factor VIII Monoclonal Antibody with A1 and A3 Epitopes Which Increases Factor VIII Activity." Blood 108, nr 11 (16.11.2006): 1702. http://dx.doi.org/10.1182/blood.v108.11.1702.1702.
Pełny tekst źródłaGale, Andrew J., Diana Rozenshteyn i Justin Riceberg. "The Neutrophil Proteases, Elastase and Cathepsin G, May Modulate the Activity of Factor VIII." Blood 108, nr 11 (16.11.2006): 1716. http://dx.doi.org/10.1182/blood.v108.11.1716.1716.
Pełny tekst źródłaNogami, Keiji, Katsumi Nishiya, Yoshihiko Sakurai, Ichiro Tanaka, John Giddings, Evgueni Saenko, Akira Yoshioka i Midori Shima. "Human Factor VIII Inhibitor Alloantibodies with a C2 Epitope Inhibit Factor Xa-catalyzed Factor VIII Activation: A new Anti-factor VIII Inhibitory Mechanism". Thrombosis and Haemostasis 87, nr 03 (2002): 459–65. http://dx.doi.org/10.1055/s-0037-1613026.
Pełny tekst źródłaOkayama, Yusuke, Masato Bingo, Kazuki Sakatoku, Hiroshi Okamura, Satoru Nanno, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino i Hirohisa Nakamae. "The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A". Blood Coagulation & Fibrinolysis 34, nr 6 (19.07.2023): 419–22. http://dx.doi.org/10.1097/mbc.0000000000001243.
Pełny tekst źródłaTakeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto i Midori Shima. "Factor VIII A2 Domain Contains a Binding Site for Factor X". Blood 124, nr 21 (6.12.2014): 4226. http://dx.doi.org/10.1182/blood.v124.21.4226.4226.
Pełny tekst źródłaNeuenschwander, Pierre F. "Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo." Blood 106, nr 11 (16.11.2005): 1020. http://dx.doi.org/10.1182/blood.v106.11.1020.1020.
Pełny tekst źródłaYork, Elizabeth S., Jasmine Ito i Glaivy Batsuli. "Investigating persistent factor VIII-specific IgM in the humoral immune response to factor VIII". Journal of Immunology 210, nr 1_Supplement (1.05.2023): 229.12. http://dx.doi.org/10.4049/jimmunol.210.supp.229.12.
Pełny tekst źródłaYada, Koji, Keiji Nogami, Kenichi Ogiwara i Midori Shima. "A novel mechanism of Enhancing the Haemostatic Effect in the Combination with Recombinant Factor VIII and Activated Prothrombin Complex Concentrate(APCC) in Hemophilia A Patients with Inhibitor". Blood 118, nr 21 (18.11.2011): 1178. http://dx.doi.org/10.1182/blood.v118.21.1178.1178.
Pełny tekst źródłaHsu, Ting-Chang, Kathleen P. Pratt i Arthur R. Thompson. "The factor VIII C1 domain contributes to platelet binding". Blood 111, nr 1 (1.01.2008): 200–208. http://dx.doi.org/10.1182/blood-2007-01-068957.
Pełny tekst źródłaGrushin, Kirill, Jaimy Miller, Daniela Dalm i Svetla Stoilova-McPhie. "Factor VIII organisation on nanodiscs with different lipid composition". Thrombosis and Haemostasis 113, nr 04 (lipiec 2015): 741–49. http://dx.doi.org/10.1160/th14-09-0725.
Pełny tekst źródłaRussell, Joshua, Yesim Dargaud, Randal J. Kaufman, Claude Negrier i Steven W. Pipe. "Inactivation-Resistant Recombinant Factor VIII Exhibits Superior Thrombin Generation Capacity in Comparison to Wild-Type and B Domain-Deleted Factor VIII." Blood 108, nr 11 (16.11.2006): 1604. http://dx.doi.org/10.1182/blood.v108.11.1604.1604.
Pełny tekst źródłaFoster, PA, CA Fulcher, RA Houghten i TS Zimmerman. "Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine". Blood 75, nr 10 (15.05.1990): 1999–2004. http://dx.doi.org/10.1182/blood.v75.10.1999.bloodjournal75101999.
Pełny tekst źródłaHealey, John F., Ernest Parker i John (Pete) S. Lollar. "Comparative Decay Rates of Human, Rhesus Macaque, Cynomolgus, and Porcine Activated Factor VIII." Blood 114, nr 22 (20.11.2009): 3164. http://dx.doi.org/10.1182/blood.v114.22.3164.3164.
Pełny tekst źródłaNovakovic, Valerie A., David B. Cullinan, Hironao Wakabayashi, Philip J. Fay, James D. Baleja i Gary E. Gilbert. "Membrane-binding properties of the Factor VIII C2 domain". Biochemical Journal 435, nr 1 (15.03.2011): 187–96. http://dx.doi.org/10.1042/bj20101797.
Pełny tekst źródłaFoster, PA, CA Fulcher, RA Houghten i TS Zimmerman. "Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine". Blood 75, nr 10 (15.05.1990): 1999–2004. http://dx.doi.org/10.1182/blood.v75.10.1999.1999.
Pełny tekst źródłaLivnat, Tami, Amy L. Dunn, Shirley Azar-Avivi, Wallace Hunter Baldwin, Gili Kenet i Shannon L. Meeks. "Epitope Specific Discrepancies Between Antibody Mediated Inhibition Of Recombinant Factor VIII and Plasma Derived Factor VIII Containing Von Willebrand Factor Affecting All Domains Of Factor VIII". Blood 122, nr 21 (15.11.2013): 1089. http://dx.doi.org/10.1182/blood.v122.21.1089.1089.
Pełny tekst źródłaLannert, Kerry W., Hilary S. Gammill, Barbara A. Konkle i Jill M. Johnsen. "The Ability of Von Willebrand Factor (VWF) to Bind Factor VIII (FVIII) Can Decrease during Pregnancy". Blood 124, nr 21 (6.12.2014): 4244. http://dx.doi.org/10.1182/blood.v124.21.4244.4244.
Pełny tekst źródłaGangadharan, Bagirath, H. Trent Spencer, Ernest T. Parker i Christopher B. Doering. "High-Level Expression of Porcine Factor VIII from Murine Mesenchymal Stem Cells." Blood 104, nr 11 (16.11.2004): 5281. http://dx.doi.org/10.1182/blood.v104.11.5281.5281.
Pełny tekst źródłaMinami, Hiroaki, Keiji Nogami, Takehisa Kitazawa, Kunihiro Hattori i Midori Shima. "FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910". Blood 124, nr 21 (6.12.2014): 1481. http://dx.doi.org/10.1182/blood.v124.21.1481.1481.
Pełny tekst źródłaNovakovic, Valerie A., James D. Baleja i Gary E. Gilbert. "The Factor VIIII C2 Domain Shows Stereospecificity for Phosphatidyl-L-Serine and Increases Factor IXa Activity". Blood 112, nr 11 (16.11.2008): 3090. http://dx.doi.org/10.1182/blood.v112.11.3090.3090.
Pełny tekst źródłaRolli, Veronique, Nathalie Enjolras, Cecile Ducasse, Marie-Helene Rodriguez, Thomas Weimer, Hans-Peter Hauser, Claude Negrier i Jean-Luc Plantier. "Generation of Factor VIII Molecules Partially Resistant to Activated Protein C." Blood 104, nr 11 (16.11.2004): 1729. http://dx.doi.org/10.1182/blood.v104.11.1729.1729.
Pełny tekst źródłaMarkovitz, Rebecca C., John F. Healey, W. Hunter Baldwin, Ernest T. Parker, Shannon L. Meeks i Pete Lollar. "Decreasing the Humoral Response to Factor VIII By Targeted Deletion of Factor VIII - Specific B Cells". Blood 124, nr 21 (6.12.2014): 238. http://dx.doi.org/10.1182/blood.v124.21.238.238.
Pełny tekst źródłaMazurier, Claudine, Armelle Parquet-Gernez i Maurice Goudemand. "Validation of a Procedure for Potency Assessing of a High Purity Factor VIII Concentrate -Comparison of Different Factor VIII Coagulant Assays and Effect of Prediluent". Thrombosis and Haemostasis 64, nr 02 (1990): 251–55. http://dx.doi.org/10.1055/s-0038-1647295.
Pełny tekst źródłaPlanque, Stephanie, Miguel A. Escobar, Hiroaki Taguchi, Sangeeta Karle, Yasuhiro Nishiyama, Elizabeth Donnachie i Sudhir Paul. "Irreversible Blockade of Factor VIII Antibodies." Blood 104, nr 11 (16.11.2004): 1728. http://dx.doi.org/10.1182/blood.v104.11.1728.1728.
Pełny tekst źródłaFu, Richard, Meghan J. Lyle, Xuefeng Wang i Carol H. Miao. "Factor VIII-specific CAR regulatory T cells modulate murine anti-factor VIII immune responses". Journal of Immunology 196, nr 1_Supplement (1.05.2016): 126.13. http://dx.doi.org/10.4049/jimmunol.196.supp.126.13.
Pełny tekst źródłaHausl, Christina, Rafi U. Ahmad, Maria Sasgary, Christopher B. Doering, Pete S. Lollar, Guenter Richter, Hans Peter Schwarz, Peter L. Turecek i Birgit M. Reipert. "Inhibition of Factor VIII-Specific Memory B Cell Responses by Supra-Physiological Concentrations of Factor VIII." Blood 104, nr 11 (16.11.2004): 38. http://dx.doi.org/10.1182/blood.v104.11.38.38.
Pełny tekst źródłaMertens, Koen, David Gestel, Gunny van Stempvoort, Vincent Limburg, Ed E. Moret i Alexander B. Meijer. "Somatic Mutations in Factor VIII Inhibitors Determine Their Factor VIII Binding and Inhibitory Properties." Blood 110, nr 11 (16.11.2007): 1762. http://dx.doi.org/10.1182/blood.v110.11.1762.1762.
Pełny tekst źródłaTang, Liang, Clark Pan, Harpartap Atwal, Jennifer Nixon, Thomas Barnett, John E. Murphy, Baisong Mei i Michael Fournel. "PEGylation of Factor VIII Reduces the Inhibitory Effects of Human Antibody Inhibitors on the Factor VIII Molecule." Blood 108, nr 11 (16.11.2006): 4017. http://dx.doi.org/10.1182/blood.v108.11.4017.4017.
Pełny tekst źródłaNogami, Keiji, Midori Shima, Tomoko Matsumoto, Katsumi Nishiya, Masahiro Takeyama, Kohei Tatsumi, Ichiro Tanaka i Akira Yoshioka. "Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII." Blood 106, nr 11 (16.11.2005): 1017. http://dx.doi.org/10.1182/blood.v106.11.1017.1017.
Pełny tekst źródła